JP2019520340A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019520340A5 JP2019520340A5 JP2018562993A JP2018562993A JP2019520340A5 JP 2019520340 A5 JP2019520340 A5 JP 2019520340A5 JP 2018562993 A JP2018562993 A JP 2018562993A JP 2018562993 A JP2018562993 A JP 2018562993A JP 2019520340 A5 JP2019520340 A5 JP 2019520340A5
- Authority
- JP
- Japan
- Prior art keywords
- faecalibacterium
- pharmaceutical composition
- microbial preparation
- purified
- growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662344053P | 2016-06-01 | 2016-06-01 | |
| US62/344,053 | 2016-06-01 | ||
| PCT/US2017/035449 WO2017210428A1 (en) | 2016-06-01 | 2017-06-01 | Compositions and methods for treating inflammatory bowel diseases (ibds) and other disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019520340A JP2019520340A (ja) | 2019-07-18 |
| JP2019520340A5 true JP2019520340A5 (enExample) | 2020-08-13 |
Family
ID=60479147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018562993A Pending JP2019520340A (ja) | 2016-06-01 | 2017-06-01 | 炎症性腸疾患（ｉｂｄ）および他の障害を治療するための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20170348360A1 (enExample) |
| EP (1) | EP3462882A4 (enExample) |
| JP (1) | JP2019520340A (enExample) |
| CN (1) | CN109803534A (enExample) |
| AU (1) | AU2017274416C1 (enExample) |
| CA (1) | CA3026414A1 (enExample) |
| WO (1) | WO2017210428A1 (enExample) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102534545B1 (ko) | 2015-05-22 | 2023-05-18 | 아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 | 자폐 스펙트럼 장애 및 관련된 증상을 치료하는 방법 |
| US20170360848A1 (en) | 2016-06-15 | 2017-12-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods for treating autism spectrum disorder and associated symptoms |
| WO2018071536A1 (en) | 2016-10-11 | 2018-04-19 | Crestovo Holdings Llc | Compositions and methods for treating primary sclerosing cholangitis and related disorders |
| WO2018071537A1 (en) | 2016-10-11 | 2018-04-19 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
| EP3606325B1 (en) | 2017-04-03 | 2024-09-04 | Gusto Global, LLC | Rational design of microbial-based biotherapeutics |
| US11040073B2 (en) | 2017-04-05 | 2021-06-22 | Finch Therapeutics Holdings Llc | Compositions and methods for treating diverticulitis and related disorders |
| EP3606541A1 (en) | 2017-04-05 | 2020-02-12 | Crestovo Holdings LLC | Compositions and methods for treating parkinson's disease (pd) and related disorders |
| JP2020521760A (ja) | 2017-05-26 | 2020-07-27 | クレストヴォ・ホールディングス・エルエルシー | 糞便微生物ベースの治療剤を含む凍結乾燥組成物ならびにそれを製造および使用する方法 |
| MY201921A (en) * | 2017-06-16 | 2024-03-23 | Biofermin Pharmaceutical Co Ltd | Agent for preventing or treating fat-associated diseases and/or inflammation |
| WO2018236979A1 (en) * | 2017-06-20 | 2018-12-27 | Cornell University | Probiotic compositions and methods |
| JP2020530494A (ja) | 2017-08-07 | 2020-10-22 | フィンチ セラピューティクス、インコーポレイテッド． | 健康な腸バリアを維持及び回復するための組成物及び方法 |
| AU2018379996A1 (en) | 2017-12-05 | 2020-06-25 | BioPlx, Inc. | Methods and compositions to prevent microbial infection |
| EP3725321A4 (en) * | 2017-12-12 | 2021-09-08 | Morinaga Milk Industry Co., Ltd. | COMPOSITION WITH A BACTERIUM OF THE GENUS BIFIDOBACTERIUM AS THE ACTIVE SUBSTANCE |
| GB2585291B (en) * | 2018-02-02 | 2023-07-19 | Univ Hong Kong Chinese | Fecal fungome and therapeutic efficacy of fecal microbiota transplantation |
| WO2019157566A1 (en) * | 2018-02-16 | 2019-08-22 | St Vincent's Hospital (Melbourne) Limited | Compositions and methods for promoting gut health |
| AU2019253616A1 (en) * | 2018-04-13 | 2020-11-05 | Med-Life Discoveries Lp | Long chain dicarboxylic fatty acid (LCDFA) producing microbes and uses thereof |
| CN110396538B (zh) * | 2018-04-24 | 2023-05-23 | 深圳华大生命科学研究院 | 偏头痛生物标志物及其用途 |
| US11166990B2 (en) | 2018-07-13 | 2021-11-09 | Finch Therapeutics Holdings Llc | Methods and compositions for treating ulcerative colitis |
| US12144834B2 (en) * | 2018-09-13 | 2024-11-19 | Xbiome Inc. | Methods and compositions for treating gastrointestinal and inflammatory disorders |
| EP3856212A1 (en) | 2018-09-27 | 2021-08-04 | Finch Therapeutics Holdings LLC | Compositions and methods for treating epilepsy and related disorders |
| US20220218761A1 (en) * | 2019-05-06 | 2022-07-14 | The General Hospital Corporation | Monitoring and altering the gut microbiome in disease |
| US11766464B2 (en) | 2019-07-11 | 2023-09-26 | Antony MILIS | Method for gut mucosa preparation to enhance microbial engraftment |
| PH12021553137A1 (en) | 2019-07-19 | 2022-07-25 | Finch Therapeutics Holdings Llc | Methods and products for treatment of gastrointestinal disorders |
| CN110541026A (zh) * | 2019-08-17 | 2019-12-06 | 昆明医科大学第一附属医院 | 一种检测溃疡性结肠炎的生物标志物及应用 |
| EP4045069A1 (en) * | 2019-10-18 | 2022-08-24 | Thaena Inc. | Fecal-derived sterile postbiotic composition and method therefor |
| EP3838276A1 (en) * | 2019-12-17 | 2021-06-23 | Exeliom Biosciences | Association of faecalibacterium prausnitzii strain cncm i-4573 with pentasa® for the treatment and prevention of gastrointestinal inflammation |
| EP3839072A1 (en) * | 2019-12-17 | 2021-06-23 | Luxia Scientific | Bacterial combinations predictive of the activity of multiple sclerosis |
| CN115515435A (zh) * | 2020-02-11 | 2022-12-23 | 沃尔夫森医疗中心 | 有效治疗溃疡性结肠炎的方法 |
| WO2021163672A1 (en) * | 2020-02-14 | 2021-08-19 | Cornell University | Transferable microbiota for the treatment of ulcerative colitis |
| CN111304120B (zh) * | 2020-02-24 | 2021-07-23 | 浙江大学 | Blautia sp B2132菌在预防和/或治疗炎症性肠病中的应用 |
| EP3875098A1 (en) * | 2020-03-04 | 2021-09-08 | Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement | Use of coprococcus bacteria for the treatment of metabolic syndrome and inflammatory bowel diseases |
| US11744866B2 (en) | 2020-03-18 | 2023-09-05 | Sabine Hazan | Methods of preventing and treating COVID-19 infection with probiotics |
| CN115697084A (zh) * | 2020-04-01 | 2023-02-03 | 沃尔夫森医疗中心 | 溃疡性结肠炎膳食、配方、产品及其方法 |
| EP4161541A4 (en) * | 2020-06-09 | 2024-09-11 | Flagship Pioneering Innovations VI, LLC | PHYSIOLOGICALLY ACCEPTABLE COMPOSITIONS CONTAINING MICROORGANISMS OR MICROBIAL PRODUCTS |
| KR102169795B1 (ko) * | 2020-06-24 | 2020-10-27 | 주식회사 엔테로바이옴 | 신규한 피칼리박테리움 프로스니치 eb-fpdk9 균주 및 그의 용도 |
| KR102169794B1 (ko) | 2020-06-24 | 2020-10-27 | 주식회사 엔테로바이옴 | 신규한 피칼리박테리움 프로스니치 균주 eb-fpdk11 및 그의 용도 |
| EP4188110A4 (en) * | 2020-07-30 | 2024-08-14 | Bactana Corp. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISEASES |
| CN111888381A (zh) * | 2020-09-18 | 2020-11-06 | 广西细微生物科技有限责任公司 | 一种肠道微生物移植工艺 |
| WO2022065957A1 (ko) * | 2020-09-28 | 2022-03-31 | 주식회사 천랩 | 미생물을 포함하는 염증성 질환 진단 또는 치료용 조성물 |
| JP2024513706A (ja) * | 2021-04-01 | 2024-03-27 | メディビーコン，インク． | 粘膜治癒をモニタリングする方法 |
| EP4082545A1 (en) * | 2021-04-27 | 2022-11-02 | Diotheris | Combination product and methods for preventing the emergence of antibiotic-resistant bacteria under antibiotic treatment |
| KR102337993B1 (ko) * | 2021-10-27 | 2021-12-14 | 주식회사 바이오뱅크힐링 | 클로스트리디움 렙텀 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
| CN113974159B (zh) * | 2021-11-02 | 2023-06-27 | 美益添生物医药(武汉)有限公司 | 齿叶乳香树树脂在制备促进肠道有益菌增殖的产品中的应用 |
| CN119183380A (zh) * | 2022-05-13 | 2024-12-24 | 国立大学法人东京大学 | 对炎症性肠病(ibd)进行治疗或诊断的方法和组合物 |
| CN115944655A (zh) * | 2023-02-14 | 2023-04-11 | 上海奇诺普森生物科技有限责任公司 | 一种肠菌组合物及其在防治自闭症中的应用 |
| CN119970806B (zh) * | 2025-02-25 | 2026-03-03 | 浙江大学 | 多毛假解黄酮菌在制备预防、治疗和/或改善溃疡性结肠炎的药物中的应用 |
| CN119709558B (zh) * | 2025-02-26 | 2025-05-30 | 昆明医科大学第一附属医院(云南省皮肤病医院) | 布劳特氏菌emf75-02b1b及其用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1510821A1 (en) * | 2003-08-27 | 2005-03-02 | Universiteit Utrecht Holding B.V. | Diagnosis and treatment of mycobacterial infections |
| EP3424515A3 (en) * | 2010-08-04 | 2019-06-19 | Thomas Julius Borody | Stool collection devices and methods for using them |
| US9968638B2 (en) * | 2011-03-09 | 2018-05-15 | Regents Of The University Of Minnesota | Compositions and methods for transplantation of colon microbiota |
| US20140363397A1 (en) * | 2011-09-14 | 2014-12-11 | Queen's University At Kingston | Method for treatment of disorders of the gastrointestinal system |
| BR112015009975A2 (pt) * | 2012-11-01 | 2017-07-11 | Academisch Ziekenhuis Groningen | métodos e composições para a estimulação das bactérias benéficas no trato gastrointestinal |
| JP2016509003A (ja) * | 2013-02-04 | 2016-03-24 | セレス セラピューティクス インコーポレイテッド | 組成物および方法 |
| BR112015020819A2 (pt) * | 2013-03-05 | 2017-07-18 | Academisch Ziekenhuis Groningen | uso de faecalibacterium prausnitzii htf-f (dsm 26943) para supressão de inflamação |
| US20150246081A1 (en) * | 2014-03-03 | 2015-09-03 | Shayne Kenneth Morris | Probiotics with methods for growth and use separately and in combination |
| US9783858B2 (en) * | 2014-04-02 | 2017-10-10 | Northwestern University | Altered microbiome of chronic pelvic pain |
| MA41020A (fr) * | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
-
2017
- 2017-06-01 WO PCT/US2017/035449 patent/WO2017210428A1/en not_active Ceased
- 2017-06-01 US US15/611,338 patent/US20170348360A1/en not_active Abandoned
- 2017-06-01 JP JP2018562993A patent/JP2019520340A/ja active Pending
- 2017-06-01 CN CN201780043664.8A patent/CN109803534A/zh active Pending
- 2017-06-01 EP EP17807481.1A patent/EP3462882A4/en not_active Withdrawn
- 2017-06-01 AU AU2017274416A patent/AU2017274416C1/en active Active
- 2017-06-01 CA CA3026414A patent/CA3026414A1/en not_active Abandoned
-
2020
- 2020-12-28 US US17/135,544 patent/US20210106629A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019520340A5 (enExample) | ||
| Ojetti et al. | The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial | |
| Bergogne-Berezin | Treatment and prevention of antibiotic associated diarrhea | |
| AU2018230495B2 (en) | Compositions and methods for promoting a healthy microbial flora in a mammal | |
| US20210030818A1 (en) | Compositions for use in balancing microbiome | |
| JP2016529309A5 (enExample) | ||
| RU2011139211A (ru) | Бактериальные штаммы, обладающие высокой противовоспалительной активностью | |
| BRPI0517273B1 (pt) | composição contendo uma mistura de três bactérias probióticas, uso desta para a prevenção e/ou tratamento de infecções do trato respiratório superior e na regularização da funcionalidade intestinal do organismo acometido por essas patologias e kit contendo uma mistura de três bactérias probióticas | |
| JP2015519329A5 (enExample) | ||
| CA3011977A1 (en) | Treatment for modulating gut microbiota | |
| BR112020019979A2 (pt) | Composições e métodos para tratamento de doenças inflamatórias intestinais | |
| CN116367823A (zh) | 直接递送维生素以抑制微生物病原体 | |
| WO2018187467A1 (en) | Compositions and methods for treating parkinson's disease (pd) and related disorders | |
| WO2018136490A1 (en) | Compositions and methods for common colds | |
| ITMI950378A1 (it) | Associazioni di fermenti lattici e lisati di saccaromiceti loro uso terapeutico e composizioni che le contengono | |
| CN114585380A (zh) | 胃肠健康组合物 | |
| US10960034B2 (en) | MRSA infection protective agent | |
| Schultz et al. | Escherichia coli Nissle 1917 | |
| WO2021097288A1 (en) | Compositions and methods for treating neurodegenerative diseases | |
| CN111491643B (zh) | 预防或治疗耐药感染的含益生菌和益生元的药物组合物 | |
| EP3979834B1 (fr) | Composition comprenant une levure pour la prevention de la cystite simple et/ou recidivante | |
| CN117919265A (zh) | 婴儿双歧杆菌及其代谢产物肌苷在制备预防和治疗心肌缺血/再灌注损伤药物中的应用 | |
| US20230404970A1 (en) | Direct delivery of vitamins to rebalance gut microbiome after exposure to antibiotics | |
| CN111436612A (zh) | 一种体内酵素及其制备方法与在抑制新型病毒方面的应用 | |
| RU2614730C1 (ru) | Антибактериальное средство и способ лечения кишечного иерсиниоза, или псевдотуберкулеза, или эшерихиоза |